Mortality Due to Cancer 2020: Benchmarking Cancer Mortality in Canada

The Conference Board of Canada, 30 pages, December 15, 2020
Primer by , ,
(You must be signed in and entitled to rate this report)


This report examines cancer mortality rates in Canada, with a focus on lung, colorectal, and prostate cancers, and compares our national and provincial rates against those of 16 peer countries.

Document Highlights

Cancer is the second leading cause of death globally and, in Canada, accounts for nearly one-third of deaths. Although deaths from cancer in Canada have decreased over the past two decades, many are still avoidable. To do better, we first need to know the full impact of cancer and how we compare with peer countries.

This report examines cancer mortality rates in Canada, with a focus on lung, colorectal, and prostate cancers. It compares the age-standardized mortality rates of Canada and the provinces against 16 peer countries with similar economic and socio-demographic profiles. The comparison highlights top-performing jurisdictions and encourages sharing of best practices. The report is an update of the last How Canada Performs health report.

Cancer has an enormous impact on patients and their families, the health care system, society, and the economy. Any advancement to reduce incidence and mortality rates is invaluable. Mortality due to cancer varies between jurisdictions. The current research shows Canada ranks average and its provinces relatively low and that they should aim for improvement.

Table of Contents

Highlights

Introduction

How Canada measures up

Policy implications and conclusions

Appendix A—Methodology

Appendix B—Visualization of grading criteria and results

Appendix C—Summary benchmarking results

Appendix D—Bibliography

COVID-19: Get all the insights

Price: $0

No charge, funded by The Conference Board of Canada and/or the research sponsor

Browse by...
Need Help?